In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer

Summary: Endometrial cancer (EC) is one of the most common gynecological cancers worldwide. Sentinel lymph node (SLN) status could be a major prognostic factor in evaluation of EC, but several prospective studies need to be performed. Here we report an in-depth proteomics analysis showing significan...

Full description

Bibliographic Details
Main Authors: Soulaimane Aboulouard, Maxence Wisztorski, Marie Duhamel, Philippe Saudemont, Tristan Cardon, Fabrice Narducci, Anne-Sophie Lemaire, Firas Kobeissy, Eric Leblanc, Isabelle Fournier, Michel Salzet
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Cell Reports Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666379121001610
_version_ 1818741642600906752
author Soulaimane Aboulouard
Maxence Wisztorski
Marie Duhamel
Philippe Saudemont
Tristan Cardon
Fabrice Narducci
Anne-Sophie Lemaire
Firas Kobeissy
Eric Leblanc
Isabelle Fournier
Michel Salzet
author_facet Soulaimane Aboulouard
Maxence Wisztorski
Marie Duhamel
Philippe Saudemont
Tristan Cardon
Fabrice Narducci
Anne-Sophie Lemaire
Firas Kobeissy
Eric Leblanc
Isabelle Fournier
Michel Salzet
author_sort Soulaimane Aboulouard
collection DOAJ
description Summary: Endometrial cancer (EC) is one of the most common gynecological cancers worldwide. Sentinel lymph node (SLN) status could be a major prognostic factor in evaluation of EC, but several prospective studies need to be performed. Here we report an in-depth proteomics analysis showing significant variations in the SLN protein landscape in EC. We show that SLNs are correlated to each tumor grade, which strengthens evidence of SLN involvement in EC. A few proteins are overexpressed specifically at each EC tumor grade and in the corresponding SLN. These proteins, which are significantly variable in both locations, should be considered potential markers of overall survival. Five major proteins for EC and SLN (PRSS3, PTX3, ASS1, ALDH2, and ANXA1) were identified in large-scale proteomics and validated by immunohistochemistry. This study improves stratification and diagnosis of individuals with EC as a result of proteomics profiling of SLNs.
first_indexed 2024-12-18T01:59:52Z
format Article
id doaj.art-b47cfe60665344049f18363e895cfa87
institution Directory Open Access Journal
issn 2666-3791
language English
last_indexed 2024-12-18T01:59:52Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Cell Reports Medicine
spelling doaj.art-b47cfe60665344049f18363e895cfa872022-12-21T21:24:47ZengElsevierCell Reports Medicine2666-37912021-06-0126100318In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancerSoulaimane Aboulouard0Maxence Wisztorski1Marie Duhamel2Philippe Saudemont3Tristan Cardon4Fabrice Narducci5Anne-Sophie Lemaire6Firas Kobeissy7Eric Leblanc8Isabelle Fournier9Michel Salzet10Université Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France; Department of Gynecology Oncology, Oscar Lambret Center, 59000 Lille, FranceUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France; Department of Gynecology Oncology, Oscar Lambret Center, 59000 Lille, FranceDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, LebanonUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France; Department of Gynecology Oncology, Oscar Lambret Center, 59000 Lille, France; Corresponding authorUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France; Corresponding authorUniversité Lille, INSERM, CHU Lille, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), 59000 Lille, France; Corresponding authorSummary: Endometrial cancer (EC) is one of the most common gynecological cancers worldwide. Sentinel lymph node (SLN) status could be a major prognostic factor in evaluation of EC, but several prospective studies need to be performed. Here we report an in-depth proteomics analysis showing significant variations in the SLN protein landscape in EC. We show that SLNs are correlated to each tumor grade, which strengthens evidence of SLN involvement in EC. A few proteins are overexpressed specifically at each EC tumor grade and in the corresponding SLN. These proteins, which are significantly variable in both locations, should be considered potential markers of overall survival. Five major proteins for EC and SLN (PRSS3, PTX3, ASS1, ALDH2, and ANXA1) were identified in large-scale proteomics and validated by immunohistochemistry. This study improves stratification and diagnosis of individuals with EC as a result of proteomics profiling of SLNs.http://www.sciencedirect.com/science/article/pii/S2666379121001610sentinel lymph nodesendometrial cancerproteomicsalternative proteinsghost proteomeprotein mutations
spellingShingle Soulaimane Aboulouard
Maxence Wisztorski
Marie Duhamel
Philippe Saudemont
Tristan Cardon
Fabrice Narducci
Anne-Sophie Lemaire
Firas Kobeissy
Eric Leblanc
Isabelle Fournier
Michel Salzet
In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
Cell Reports Medicine
sentinel lymph nodes
endometrial cancer
proteomics
alternative proteins
ghost proteome
protein mutations
title In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
title_full In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
title_fullStr In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
title_full_unstemmed In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
title_short In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
title_sort in depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
topic sentinel lymph nodes
endometrial cancer
proteomics
alternative proteins
ghost proteome
protein mutations
url http://www.sciencedirect.com/science/article/pii/S2666379121001610
work_keys_str_mv AT soulaimaneaboulouard indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT maxencewisztorski indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT marieduhamel indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT philippesaudemont indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT tristancardon indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT fabricenarducci indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT annesophielemaire indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT firaskobeissy indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT ericleblanc indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT isabellefournier indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer
AT michelsalzet indepthproteomicsanalysisofsentinellymphnodesfromindividualswithendometrialcancer